Austrian Medicines Verification Systems (AMVS), which is handling the digital security system for prescription drugs in Austria from operational perspective has extended its management. Christoph Lendl (38) has joined as managing director alongside Andreas Achrainer on July 1, 2019. Christoph holds a master’s degree in business administration and has many years of experience in various finance functions. He most recently served as finance lead for the biotechnology group AMGEN in Slovakia.
The press release (in German only) can be downloaded here: